Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-07-31): -0.86.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 15 comparable quarters.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-6.41
EARNINGS PER SHARE (EPS) AVG 3Y
-27.87
EARNINGS PER SHARE (EPS) AVG 5Y
-55.81
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
HeartSciences Inc.
Market Cap
$7.97M
Earnings Per Share (EPS)
N/A
TTM Avg
-6.41
3Y Avg
-27.87
5Y Avg
-55.81
Market Cap
$7.95M
Earnings Per Share (EPS)
-6.39
TTM Avg
-9.59
3Y Avg
-7.41
5Y Avg
-7.93
Market Cap
$8.01M
Earnings Per Share (EPS)
-104.00
TTM Avg
-164.88
3Y Avg
-121.81
5Y Avg
-116.67
Market Cap
$7.83M
Earnings Per Share (EPS)
-23.59
TTM Avg
-251.09
3Y Avg
-121778.80
5Y Avg
-249058.36
Market Cap
$7.76M
Earnings Per Share (EPS)
-68.91
TTM Avg
-299.00
3Y Avg
-268.50
5Y Avg
-367.67
Market Cap
$8.14M
Earnings Per Share (EPS)
-1.08
TTM Avg
-2.14
3Y Avg
-342.00
5Y Avg
-242.25
Market Cap
$8.32M
Earnings Per Share (EPS)
N/A
TTM Avg
-39.00
3Y Avg
-20.98
5Y Avg
-20.98
Market Cap
$8.47M
Earnings Per Share (EPS)
-65.58
TTM Avg
-8524.08
3Y Avg
-26524.29
5Y Avg
-21051.80
Market Cap
$7.31M
Earnings Per Share (EPS)
-3.48
TTM Avg
-5.74
3Y Avg
-24.14
5Y Avg
-2936.24
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartSciences Inc. (HSCS) | $7.97M | N/A | -6.41 | -27.87 | -55.81 |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.95M | -6.39 | -9.59 | -7.41 | -7.93 |
| GT Biopharma, Inc. (GTBP)vs › | $8.01M | -104.00 | -164.88 | -121.81 | -116.67 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.83M | -23.59 | -251.09 | -121778.80 | -249058.36 |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.76M | -68.91 | -299.00 | -268.50 | -367.67 |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.14M | -1.08 | -2.14 | -342.00 | -242.25 |
| DataMEDS AI, Inc. (MEDS)vs › | $8.32M | N/A | -39.00 | -20.98 | -20.98 |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.47M | -65.58 | -8524.08 | -26524.29 | -21051.80 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -3.48 | -5.74 | -24.14 | -2936.24 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.24M | -7.38 | -1.62 | -0.82 | -0.82 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-2.46
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.48 |
| 2025-04-30 | -9.34 |
| 2024-04-30 | -18.74 |
| 2023-04-30 | -79.92 |
| 2022-04-30 | -145.48 |
| 2021-04-30 | -77.89 |
| 2020-04-30 | -115.69 |
